MetAP2, New Target for S100A4
3 Calcium-binding proteins transduce intracellular calcium signals to many biological processes including protein phosphorylation, enzyme activities, cell proliferation and differentiation, dynamics of cytoskeletal organization and Ca 2+ homeostasis, and regulate the cytosolic Ca 2+ level (1) . S100 proteins are structurally related to the wellknown EF-hand calcium-binding proteins such as calmodulin and troponin C, and comprise 19 members that are differentially expressed in a variety of cell types (2-4). S100A4, one of the members of S100 protein family, is a small acidic protein consisting of 101 amino acid residues (2) (3) (4) . Expression of the S100A4 gene (also known as pEL98 /mts1/p9Ka/18A2/calvasculin/CAPL) has been implied to concern cell cycle progression, cell differentiation, and neoplastic progression (2) (3) (4) . In particular, the observations that S100A4 is involved in tumor cell invasion and metastasis have attracted attention. It has been shown that S100A4 is highly expressed in different rodent invasive and metastatic tumor cells (5, 6) and that manipulation of the expression of S100A4 in tumor cells results in the alteration of their invasive and metastatic potential (7) (8) (9) (10) . In addition, we and others have recently demonstrated that the elevated levels of S100A4 are associated with the more malignant phenotype and prognosis in human breast and colorectal adenocarcinoma specimens (11, 12) .
Although the precise mechanisms by which S100A4 affects the invasive and metastatic phenotypes of tumor cells remain to be solved, the expression level of S100A4 has been shown to correlate positively with the expression of matrix metalloproteinases (13) and cell motility (6, 14) and negatively with the expression of E-cadherin (15, 16) .
S100A4 is also expressed in a variety of normal cells including lymphocytes and
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4 vascular endothelial cells (17, 18) . A promising approach to gain insight into the functions of this protein might be studies on its target proteins. Indeed, nonmuscle tropomyosin (19) , nonmuscle myosin heavy chain (20, 21) and F-actin (22) have been reported as the targets, suggesting a possible participation of S100A4 in the regulation of cytoskeletal dynamics and cell motility (6, 14) . More recently, two other proteins, S100A1 (23) and tumor suppressor p53 protein (24) , have been demonstrated to interact physically and functionally with S100A4.
Methionine aminopeptidase 2 (MetAP2) is one of two enzymes that catalyze the cotranslational removal of the initiator methionine residue from nascent peptides in eukaryotes (25) . In addition to its methionine aminopeptidase activity, MetAP2 is shown to regulate protein synthesis by protecting the α subunit of eukaryotic initiation factor-2 from phosphorylation (POEP activity) (26, 27) . Recently, MetAP2 has been identified as a physiologically relevant target for potent angiogenesis-inhibitors, fumagillin, and ovalicin (28, 29) . A synthetic analog of fumagillin, TNP-470, selectively and covalently binds to MetAP2 and blocks its aminopeptidase activity, but not its POEP activity, at the comparable concentrations required for inhibition of endothelial cell growth (30) . Interestingly, the growth of endothelial cells is much more sensitive to this compound than that of tumor cells (31, 32) . MetAP2 is thus thought to concern endothelial cell proliferation through N-terminal methionine processing of as yet unknown proteins essential for endothelial cell growth (30) .
In an effort to identify additional target proteins for S100A4, we employed yeast two-hybrid system and screened a cDNA library with S100A4 cDNA as a bait. Here, (36) . The screening of the library was performed essentially according to the lithium yeast transformation protocol (37) .
Briefly, yeast strain cells L40 (Invitrogen) were transformed first with the bait plasmid and selected on tryptophan-free plates to produce a stable L40-LexA-S100A4 strain.
A culture of the strain was then transformed with the pACT/cDNA library and selected on leucine-, tryptophan-, and histidine-free plates and media. The transformants thus appeared were applied to β-galactosidase colony-lift filter assay and the colonies that gave a blue color within 16 h were isolated. Both the bait-and the target-plasmids were isolated from each individual clone. The recovered pBTM116 target plasmids were cotransformed into L40 cells along with the original bait plasmid, LexA-S100A4, by guest on July 15, 2017 http://www.jbc.org/
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Construction of HA-tagged Expression Plasmids Carrying Various Length of
MetAP2 cDNA Fragments-----A full-length MetAP2 cDNA was isolated by screening a mouse lung carcinoma cDNA library with the 5'-half of MetAP2 coding sequence identified in the present study as a probe (GenBank accession No. AF434712).
Expression vectors of various truncated form of MetAP2 were constructed using a pcDNA3/HA3 vector (a gift of Dr. T. Yamochi, Keio University) and polymerase chain reaction (PCR) amplified cDNA fragments. The nucleotide sequences of the fragments were those corresponding to amino acids, Met1-Ala229 (MetAP2(1-229)), Met1-Pro109 
Construction of FLAG-tagged Expression Plasmid Harboring S100A4 Coding
Sequence-----The coding sequence of pEL98 (mouse S100A4) was amplified by PCR using the 5'-primer having Xho I recognition site at the 5' end, 5'-AGACTCG AGTCAACGGTTACCATGGCAAC-3' and the 3'-primer having Not I recognition sequence at the 5' end, 5'-ATTGCGGCCGCGAGGAGTCTTCACTTCTTCC-3'. The resulting PCR fragments were digested with Xho I and Not I, gel-purified, and then cloned into Not I/Xho I cut pME18S/FLAG vector (a gift of Dr. K.Maruyama, Tokyo
Medical and Dental University).
Construction of pGEX Plasmids for Producing Glutathione S-transferase (GST)
Fusion Proteins-----The pEL98 cDNA clone and the preparation of pGEX/pEL98 plasmid expressing GST/S100A4 fusion protein has been described previously (35, 17) .
The coding sequences of human S100A1, S100A4, S100A6 and calmodulin were amplified by reverse transcription-PCR (RT-PCR) using total RNA prepared from human brain (CLONTECH) for S100A1, and from HeLa cells for S100A4, S100A6 and blot-affinity purified using GST/MetAP2(224-478) fusion protein immobilized onto nitrocellulose membrane (38) . or 1 mM EDTA at 4 < for 60 min and then followed by the addition of glutathione-Sepharose 4B beads. After incubation for further 60 min at 4<, the beads were washed five times with the above buffer and boiled for 3 min in SDS gel sample buffer. The released materials were subjected to SDS-PAGE. The gels were fixed and treated with ENLIGHTNING (New England Nuclear, Boston, MA) before they were dried and exposed to Fuji RX medical X-ray film with an intensifying screen at -80<. Protein concentration was determined by the method of Bradford (39) using bovine serum albumin as a standard.
In Vitro Binding Assay (GST pull-down Assay)-----In vitro

Immunoprecipitation and Immunoblot Analysis-----293 cells were transfected with 5
µg of pcDNA3/HA3-J6-2 or pME18S/FLAG-S100A4 either alone or both using a 12 by SDS-PAGE using a 12.5% separating gel and blotted onto nitrocellulose filter.
Immunoblot analysis was performed using a rat monoclonal anti-HA antibody (clone 3F-10, Boehringer Mannheim), a mouse monoclonal ant-FLAG antibody (clone M2, Sigma) and the corresponding horseradish peroxidase-labeled secondary antibodies and an ECL Western blotting detection kit (Amersham). 
Preparation of Recombinant Human MetAP2-----Recombinant
RNA Extraction and Northern Blot Analysis-----Total RNA was extracted from
MSS31 cells and the mouse heart by using RNeasy kit (QIAGEN, Germany). Twenty µg of total RNA were electrophoresed on a 1% agarose gel containing formaldehyde and transferred to nylon filters. Blots were hybridized with 32 P-labeled mouse S100A1, MetAP2, New Target for S100A4 13 S100A4, S100A6 or MetAP2 cDNA that was prepared by the random primer method.
Filters were finally washed at 50< in 30 mM NaCl, 3 mM sodium citrate and 0.1% SDS.
Immunoblot Analysis of MetAP2 and S100A4 in Endothelial Cells-----MSS31 cells
were serum starved in αMEM containing 0.1 % FBS for 26 h and treated with 20 ng/ml bFGF for the following 16 h. Untreated and bFGF-treated cells were washed and lysed in 150 mM NaCl, 50 mM Tris-HCl (pH7.5), 1% Triton X-100, 1 mM EDTA, and 1 mM phenylmethylsulfonyl fluoride. Cell lysates were centrifuged at 10, 000g for 10 min at 4<, and the supernatant was used for subsequent analyses. SDS-PAGE was carried out using 12.5% acrylamide gels. Immunoblot analysis was performed using anti-S100A4 antibody, anti-MetAP2 antibody, anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH) monoclonal antibody (CHEMICON International, Inc, CA), and the corresponding secondary antibodies as described above. MetAP2, New Target for S100A4
Immunocytochemistry-----MSS31
RESULTS
Screening of Proteins Capable of Interacting with S100A4 in Yeast Cells-----To
explore a new type of target proteins capable of interacting with S100A4, we adopted (Fig.1) . was assessed by SDS-PAGE followed by fluorography. As shown in Fig. 2A ,
In vitro Interaction of S100A4 with MetAP2-----We
MetAP2
(1-229) bound to neither GST nor GST/S100A4 fusion protein in the presence of EDTA, whereas it bound to GST/S100A4 fusion protein, but not to GST, in the presence of calcium ion. The same result was obtained by using full-length mouse MetAP2, instead of MetAP2(1-229), and human S100A4 (Fig. 2B ). Recombinant human MetAP2 was also shown to interact with human S100A4 (Fig. 2C) . On the other hand, human calmodulin, another member of calcium binding protein did not interact with mouse or human MetAP2 (Fig. 2B and C) .
Interaction of Other S100 Proteins with MetAP2----The above results prompted us to
examine whether the interaction with MetAP2 is specific for S100A4 among S100
proteins. We chose human S100A1 and S100A6 on the basis of their same cytoplasmic localization and relatively high sequence homology with S100A4, and examined their interaction with MetAP2(1-229) in a GST pull-down assay. As shown in Fig. 2D , they were found to be able to interact with MetAP2(1-229) in the presence of calcium ion. However, the intensity of the band differed in each other, being in the order of S100A4êS100A1S100A6. (Fig. 3A ). The cell lysate was then subjected to immunoprecipitation with anti-S100A4 or anti-HA antibody followed by immunoblot analysis with anti-HA antibody. As shown in Fig. 3B , the MetAP2(1-229) was co-immunoprecipitated with S100A4 only from the cell lysate of the transfectant expressing both proteins. However, the amount of the co-immunoprecipitated MetAP2(1-229) was quite small, possibly due to a weak or transient interaction between S100A4 and MetAP2(1-229) under our experimental conditions. We then treated the transfected cells with the membrane-permeable chemical crosslinking agent, DSP, before cell lysis. The results shown in Fig. 3B demonstrate that the amount of the co-immunoprecipitated MetAP2(1-229) with S100A4 was greatly increased when the cells were treated with DSP, suggesting that S100A4 exists in close proximity of MetAP2(1-229) in the living cells. 
Interaction of S100A4 with MetAP2 in Mammalian Cells-----To
Binding site of S100A4 on MetAP2-----To
Expression and Localization of S100A4 and MetAP2 in Mouse Endothelial Cells-----
Northern blot analysis was carried out to examine whether S100A1, S100A4, S100A6, and MetAP2 are expressed in MSS31 cells. The results in Fig. 5A clearly demonstrate the expressions of S100A4, S100A6 and MetAP2, but not of S100A1, mRNAs in the cells.
We next examined the cellular localization of S100A4 and MetAP2 in MSS31 cells.
In quiescent cells maintained 26 h in αMEM containing 0.1% serum, both S100A4 and MetAP2 were co-localized mainly in the perinuclear region (Fig. 5B ). In the case of MetAP2, a faint nuclear staining was observed. However, as we could not detect MetAP2 in the nuclear fraction of MSS31 cells on an immunoblot (data not shown), this nuclear staining seemed to be non-specific. Upon treatment with bFGF, both proteins changed their localizations, clearly starting from 8 h after the treatment (data not shown), to a more diffuse state in the cytosol, but intriguingly, they were still co-localized in the cells (Fig. 5B) . It should be also noted that the fluorescence of MetAP2 in bFGF-treated cells was brighter than that in untreated cells, suggesting an increase in the amount of MetAP2 at the protein level. Coinciding with this observations, immunoblot analyses demonstrated that the amount of MetAP2, but not of S100A4 and GAPDH, was increased in bFGF-treated cells (Fig. 5C ).
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DISCUSSION
In the present study we demonstrated for the first time that the metastasis-associated gene product, S100A4, interacts with an angiogenesis-related protein, MetAP2.
Several lines of evidence support this conclusion. First, the nucleotide sequences of 7 out of 27 cDNA inserts of plasmids isolated from positive transformants obtained by using yeast two-hybrid system were highly homologous to that of MetAP2. Indeed, the amino acid sequence encoded by the longest cDNA insert, termed J6-2, was identical to the amino acid residues 1-229 of MetAP2. The remaining 20
transformants were found to be false-positive. Second, GST pull-down assays clearly showed that S100A4 physically interacted with MetAP2(1-229) and the full-length MetAP2 as well in a Ca 2+ dependent manner. Third, S100A4 was co-immunoprecipitated with MetAP2(1-229) from the cell lysate of 293 cells expressing both proteins. Fourth, S100A4 was co-localized with MetAP2 in both quiescent and bFGF-treated MSS31 cells.
GST pull-down assay showed that calmodulin, another member of EF-hand type calcium-binding proteins, did not interact with MetAP2. Although this observation clearly demonstrated the structural specificity of EF-hand proteins to be interacted with MetAP2, it is interesting to examine whether other S100 proteins also associate with MetAP2. S100A1 and S100A6 were chosen because of their relatively high sequence with different affinity. To date, some 19 different proteins have been assigned to the S100 protein family. They show different degrees of homology, ranging from 25 % to 65 % identity, at the amino acid level (4). It is of note that some of them share the common target proteins; for example, S100A2 and S100A4 associate with non-muscle tropomyosin and F-actin (19, 22) , S100A8, S100A9 and S100B to vimentin (4), and S100B and S100A4 to p53 (24, 40) . Therefore, the specificity of target proteins for S100 proteins is not strict, and this also seems to be true in the case of MetAP2 binding.
However, it is known that the members of S100 family have a cellular and/or restricted tissue distribution (2, 4). For instance, S100A2 is mainly localized in cell nucleus, while S100A1, S100A4, and S100A6 in cytoplasm. In this sense, there might be little chance for S100A2 to interact with MetAP2. As for tissue specific distribution, S100A1 is abundantly expressed in cardiomyocytes, slow-twitch skeletal muscle cells, salivary epithelial cells, renal cells, and hippocampal neurons, S100A2 is in lung and kidney, S100A4 is in fibroblasts, myoepithelial cells and tumor cells, while S100A6 is mainly expressed in fibroblasts and tumor cells (2, 4) . These data suggest, therefore, that individual S100 proteins might function in the cell types where they are expressed.
MetAP2 (also known as p67) is a glycoprotein, the carbohydrate moieties of which are required for its POEP activity (41, 42) . It has been reported that p67-glycosylase, which removes O-linked GlcNAc moieties from MetAP2, inactivates the POEP activity by guest on July 15, 2017
http://www.jbc.org/
Downloaded from
21
when it is activated, and subsequently increases phosphorylation of the α-subunit of elF2 (41) . Thus, the carbohydrate moieties of MetAP2 are important for its physiological function. These observations, together with the fact that the interaction between S100A4 and the in vitro translated MetAP2(1-229) was apparent but the in vivo interaction seemed to be weak and transient, led us to imagine that glycosylation state of MetAP2 might affect the interaction with S100A4. To address this question, the interaction of the recombinant human full-length MetAP2 purified from insect cells with human S100A4 was examined, because the recombinant MetAP2 was shown to be glycosylated (29) . The results showed that the interaction indeed occurred between the two proteins, clearly indicating that glycosylation is unrelated to the interaction.
It was of great interest to determine if S100A4 affects the physiological functions of MetAP2. Mammalian MetAP2 is known to be bifunctional. It exhibits not only POEP activity but also methionine aminopeptidase activity. Interestingly, it is differentiated from its prokaryotic counterpart such as E. coli MetAP1 by a highly charged N-terminus of 165 amino acid residues in length, which carries alternating polybasic and polyacidic stretches of a similarly sized segment (43) . These stretches have been thought to concern functional regulation of MetAP2 through interaction with nucleic acids and proteins (44, 45) . In fact, it is reported that the N-terminal 159 amino acids are responsible and sufficient for the POEP activity (42) . MetAP2 MetAP2, New Target for S100A4
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tried to narrow down the binding site of S100A4 on MetAP2 to determine whether the binding site resides within the N-terminal 159 amino acids. By using four deletion variants of MetAP2, the region responsible for the binding with S100A4 was found to be within 60 amino acid residues, Arg170-Ala229. This result implied that S100A4
might not directly influence the POEP activity of MetAP2, although further work is required to conclude this notion. The binding region of S100A4 was adjacent to the amino acid residue His231 to which TNP-470 binds covalently, leading to inhibition of the aminopeptidase activity (30) . Noteworthy is the finding that TNP-470 shows no effect on the POEP activity but strongly inhibits the aminopeptidase activity of MetAP2.
Thus, we tried to determine the effect of S100A4 on the aminopeptidase activity of MetAP2. Unexpectedly however, the enzymatic activity was not affected at all even in the presence of 100-fold molar excess amount of S100A4 in the reaction mixture, despite the interaction of both proteins indeed occurred under the same conditions (data not shown).
Although any direct effects of S100A4 on MetAP2 activity could not be obtained as above, we tried to address if the binding of S100A4 to MetAP2 has certain physiological meanings. We investigated the intracellular localization of both proteins in endothelial MSS31 cells. S100A4 is reported to be expressed in endothelial cells (18) and MetAP2 has been shown to play an essential role for the regulation of endothelial cell growth (30) . Indeed, Northern blot analysis confirmed the expression of S100A4 and MetAP2 in MSS31 cells. Besides S100A4, S100A6 was also expressed in the cells, whereas S100A1 was not. As the binding of S100A4 to by guest on July 15, 2017 http://www.jbc.org/
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MetAP2 was likely to be much higher than that of S100A6 in GST pull-down assay, it seems reasonable to imagine that S100A4 mainly concerns the interaction with MetAP2 in MSS31 cells. Meanwhile, immunocytochemical staining of S100A4 and MetAP2
clearly showed that both proteins were colocalized in a perinuclear zone of quiescent MSS31 cells. Upon treatment with bFGF, S100A4 changed its intracellular localization and became more diffuse in whole cytoplasm. It is known that S100A4 changes its localization in the cells when intracellular calcium level is elevated (46) .
Since a rise in intracellular calcium level was detected after treatment of MSS31 cells with bFGF (date not shown), our observation is in line with these previous studies.
Intriguingly, we noticed that MetAP2 also changed its localization, together with S100A4. Moreover, the amount of MetAP2, but not of S100A4, was increased in antibody. Upper panels, anti-MetAP2; middle panels, anti-S100A4; lower panels, merge images. C) Immunoblot analysis. Cell lysates prepared from untreated cells and the cells treated with bFGF as above were resolved by SDS-PAGE, and then transferred to a nitrocellulose filter electrophoretically. MetAP2, S100A4 and GAPDH were detected using respective antibodies and an ECL detection kit.
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